Loading
A phase 2 trial of PM8002 in colorectal cancer, run by Biotheus Inc., now recruiting.
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer is a phase 2 interventional study registered as NCT07133750 by Biotheus Inc., with 100 participants planned, started 2025-08-19 and due to reach its primary completion in 2027-05. Interventions recorded: PM8002, Chemotherapy Regimen 1, Chemotherapy Regimen 2, Chemotherapy Regimen 3. Conditions listed: CRC (Colorectal Cancer). No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares PM8002, BioNTech, Colorectal cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/